[Clinical effect and safety of pegylated interferon-α-2b injection (Y shape, 40 kD) in treatment of HBeAg-positive chronic hepatitis B patients].
Hou FQ, Yin YL, Zeng LY, Shang J, Gong GZ, Pan C, Zhang MX, Yin CB, Xie Q, Peng YZ, Chen SJ, Mao Q, Chen YP, Mao QG, Zhang DZ, Han T, Wang MR, Zhao W, Liu JJ, Han Y, Zhao LF, Luo GH, Zhang JM, Peng J, Tan DM, Li ZW, Tang H, Wang H, Zhang YX, Li J, Zhang LL, Chen L, Jia JD, Chen CW, Zhen Z, Li BS, Niu JQ, Meng QH, Yuan H, Sun YT, Li SC, Sheng JF, Cheng J, Sun L, Wang GQ.
Hou FQ, et al. Among authors: shang j.
Zhonghua Gan Zang Bing Za Zhi. 2017 Aug 20;25(8):589-596. doi: 10.3760/cma.j.issn.1007-3418.2017.08.007.
Zhonghua Gan Zang Bing Za Zhi. 2017.
PMID: 29056008
Clinical Trial.
Chinese.